18
Participants
Start Date
August 31, 2013
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
azurin-derived cell-penetrating peptide p28
Given IV
Memorial Sloan Kettering Cancer Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's National Medical Center, Washington D.C.
National Cancer Institute Pediatric Oncology Branch, Bethesda
Duke University Medical Center, Durham
St. Jude Children's Research Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Lurie Children's Hospital-Chicago, Chicago
Baylor College of Medicine, Houston
Children's Hospital Los Angeles, Los Angeles
Lucile Packard Children's Hospital Stanford University, Palo Alto
National Cancer Institute (NCI)
NIH
Pediatric Brain Tumor Consortium
NETWORK